Abstract
Astrocytes are the predominant glial cell population in the central nervous system (CNS). Once considered only passive scaffolding elements, astrocytes are now recognised as cells playing essential roles in CNS development and function. They control extracellular water and ion homeostasis, provide substrates for energy metabolism, and regulate neurogenesis, myelination and synaptic transmission. Due to these multiple activities astrocytes have been implicated in almost all brain pathologies, contributing to various aspects of disease initiation, progression and resolution. Evidence is emerging that astrocyte dysfunction can be the direct cause of neurodegeneration, as shown in Alexander’s disease where myelin degeneration is caused by mutations in the gene encoding the astrocyte-specific cytoskeleton protein glial fibrillary acidic protein. Recent studies point to a primary role for astrocytes in the pathogenesis of other genetic leukodystrophies such as megalencephalic leukoencephalopathy with subcortical cysts and vanishing white matter disease. The aim of this review is to summarize current knowledge of the pathophysiological role of astrocytes focusing on their contribution to the development of the above mentioned leukodystrophies and on new perspectives for the treatment of neurological disorders.
Article PDF
Similar content being viewed by others
References
Virchow R., Cellular pathology as based upon physiological and pathological histology, translated from German by Chance B., 1859, 2nd ed., reproduced by Dover Publications, New York, 1971, 356–382
Golgi C., Sulla struttura della sostanza grigia del cervello (comunicazione preventiva), Gazzetta Medica Italiana, Lombardia, 1873, 33, 244–246
Golgi C., Opera omnia, Hoepli, Milano, 1903
Ramon Y., Cajal S., Histologie du systeme nerveux de l’homme et des vertebres, Maloine, Paris, 1909
Peters A., Palay S.L., Webster H.F., The fine structure of the nervous system: the neurons and supporting cells, W.B. Saunders, Philadelphia, 1976, 232–248
Bignami A., Stoolmiller A.C., Astroglia-specific protein (GFA) in clonal cell lines derived from the G26 mouse glioma, Brain Res., 1979, 163, 353–357
De Keyser J., Mostert J.P., Koch M.W. J., Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders, Neurol. Sci., 2008, 267, 3–16
Powell E.M., Geller H.M., Dissection of astrocyte-mediated cues in neuronal guidance and process extension, Glia, 1999, 26, 73–83
Zaheer A., Zhong W., Uc E.Y., Moser D.R., Lim R., Expression of mRNAs of multiple growth factors and receptors by astrocytes and glioma cells: detection with reverse transcription-polymerase chain reaction, Cell. Mol. Neurobiol., 1995, 15, 221–37
Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A., Control of synapse number by glia, Science, 2001, 291, 657–661
Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., et al., Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis, Cell, 2005, 120, 421–433
Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., et al., The classical complement cascade mediates CNS synapse elimination, Cell, 2007, 131, 1164–1178
Allaman I., Belanger M., Magistretti P.J., Astrocyte-neuron metabolic relationships: for better and worse, Trends Neurosci., 2011, 34, 75–87
Bushong E.A., Martone M.E., Jones Y.Z., Ellisman M.H., Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains, J. Neurosci., 2002, 22, 183–192
Halassa M.M., Fellin T., Takano H., Dong J.H., Haydon P.G., Synaptic islands defined by the territory of a single astrocyte, J. Neurosci., 2007, 27, 6473–6477
Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., et al., Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate, Neuron, 1996, 16, 675–686
Rauen T., Taylor W.R., Kuhlbrodt K., Wiessner M., High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance, Cell Tissue Res., 1998, 291, 19–31
Verkhratsky A., Kirchhoff F., NMDA receptors in glia, Neuroscientist, 2007, 13, 28–37
Bak L.K., Schousboe A., Waagepetersen H.S., The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer, J. Neurochem., 2006, 98, 641–53
McKenna M.C., The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain, J. Neurosci. Res., 2007, 85, 3347–3358
Kimelberg H.K., Receptors on astrocytes — what possible functions?, Neurochem. Int., 1995, 26, 27–40
Perea G., Navarrete M., Araque A., Tripartite synapses: astrocytes process and control synaptic information, Trends Neurosci., 2009, 32, 421–431
Shigetomi E., Bowser D.N., Sofroniew M.V., Khakh B.S., Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons, J. Neurosci., 2008, 28, 6659–6663
Haydon P.G., Carmignoto G., Astrocyte control of synaptic transmission and neurovascular coupling, Physiol. Rev., 2006, 86, 1009–1031
Zorec R., Araque A., Carmignoto G., Haydon P.G., Verkhratsky A., Parpura V., Astroglial excitability and gliotransmission: an appraisal of Ca2+ as a signalling route, ASN Neuro., 2012, 4, e00080
Malarkey E.B., Parpura V., Mechanisms of glutamate release from astrocytes, Neurochem. Int., 2008, 52, 142–1454
Evanko D.S., Zhang Q., Zorec R., Haydon P.G., Defining pathways of loss and secretion of chemical messengers from astrocytes, Glia, 2004, 47, 233–240
Garcia-Segura L.M., Melcangi R.C., Steroids and glial cell function, Glia, 2006, 54, 485–498
Stellwagen D., Malenka R.C., Synaptic scaling mediated by glial TNFalpha, Nature, 2006, 440, 1054–1059
Abi-Saab W.M., Maggs D.G., Jones T., Jacob R., Srihari V., Thompson J., et al., Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia, J. Cereb. Blood Flow Metab., 2002, 22, 271–279
Turner D.A., Adamson D.C., Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism, J. Neuropathol. Exp. Neurol., 2011, 70, 167–176
Pellerin L., Magistretti P.J., Sweet sixteen for ANLS, J. Cereb. Blood Flow. Metab., 2012, 32, 1152–1166
Bélanger M., Allaman I., Magistretti P.J., Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation, Cell Metab., 2011, 14, 724–738
Dienel G.A., Brain lactate metabolism: the discoveries and the controversies, J. Cereb. Blood Flow Metab., 2012, 32, 1107–1138
Brown A.M., Baltan Tekkok S., Ransom B.R., Energy transfer from astrocytes to axons: the role of CNS glycogen, Neurochem. Int., 2004, 45, 529–536
Tsacopoulos M., Magistretti P.J., Metabolic coupling between glia and neurons, J. Neurosci., 1996, 16, 877–885
Amaral A.I., Effects of hypoglycaemia on neuronal metabolism in the adult brain: role of alternative substrates to glucose, J. Inherit. Metab. Dis., 2012, [Epub ahead of print] doi: 10.1007/s10545-012-9553-3
Magistretti P.J., Pellerin L., Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes, Cereb.Cortex., 1996, 6, 50–61
Kimelberg H.K., Nedergaard M., Functions of astrocytes and their potential as therapeutic targets, Neurotherapeutics, 2010, 7, 338–353
Sofroniew M.V., Vinters H.V., Astrocytes: biology and pathology, Acta Neuropathol., 2010, 119, 7–35
Gardner-Medwin A.R., Analysis of potassium dynamics in mammalian brain tissue, J. Physiol., 1983, 335, 393–426
Walz W., Role of astrocytes in the clearance of excess extracellular potassium, Neurochem. Int., 2000, 36, 291–300
Kofuji P., Newman E.A., Potassium buffering in the central nervous system, Neuroscience, 2004, 129, 1045–1056
Djukic B., Casper K.B., Philpot B.D., Chin L.S., McCarthy K.D., Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced shortterm synaptic potentiation, J. Neurosci., 2007, 27, 11354–1165
Butt A.M., Kalsi A., Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions, J. Cell. Mol. Med., 2006, 10, 33–44
D’Ambrosio R., Gordon D.S., Winn H.R., Differential role of KIR channel and Na(+)/K(+)-pump in the regulation of extracellular K(+) in rat hippocampus, J. Neurophysiol., 2002, 87, 87–102
Wang D.D., Bordey A., The astrocyte odyssey, Prog. Neurobiol., 2008, 86, 342–367
Amzica F., Massimini M., Glial and neuronal interactions during slow wave and paroxysmal activities in the neocortex, Cereb. Cortex., 2002, 12, 1101–1113
Peters A., Palay S.L., Webster H.D., The fine structure of the nervous system, 3rd ed., Oxford University Press, New York, 1991
Abbott N.J., Ronnback L., Hansson E., Astrocyte-endothelial interactions at the blood-brain barrier, Nat. Rev. Neurosci., 2006, 7, 41–53
Pellerin L., Magistretti P.J., Neuroenergetics: calling upon astrocytes to satisfy hungry neurons, Neuroscientist, 2004, 10, 53–62
Connors N.C., Adams M.E., Froehner S.C., Kofuji P., The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia, J. Biol. Chem., 2004, 279, 28387–28392
Dalloz C., Sarig R., Fort P., Yaffe D., Bordais A., Pannicke T., et al., Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina, Hum. Mol. Genet., 2003, 12, 1543–54
Amiry-Moghaddam M., Ottersen O.P., The molecular basis of water transport in the brain, Nat. Rev. Neurosci., 2003, 4, 991–1001
Benfenati V., Amiry-Moghaddam M., Caprini M., Mylonakou M.N., Rapisarda C., Ottersen O.P., et al., Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes, Neuroscience, 2007, 148, 876–892
Ridder M.C., Boor I., Lodder J.C., Postma N.L., Capdevila-Nortes X., Duarri A., et al., Megalencephalic leucoencephalopathy with cysts: defect in chloride currents and cell volume regulation, Brain, 2011, 134, 3342–3354
Ernest N.J., Weaver A.K., Van Duyn L.B., Sontheimer H.W., Relative contribution of chloride channels and transporters to regulatory volume decrease in human glioma cells, Am. J. Physiol. Cell. Physiol., 2005, 288, C1451–C1460
Teijido O., Martínez A., Pusch M., Zorzano A., Soriano E., Del Río J.A., et al., Localization and functional analyses of the MLC1 protein involved in megalencephalic leukoencephalopathy with subcortical cysts, Hum. Mol. Genet., 2004, 13, 2581–2594
Walz W., Chloride/anion channels in glial cell membranes, Glia, 2002, 40, 1–10
Hayashi Y., Nomura M., Yamagishi S., Harada S., Yamashita J., Yamamoto H., Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes, Glia, 1997, 19, 13–26
Nico B., Ribatti D., Morphofunctional aspects of the blood-brain barrier, Curr. Drug Metab., 2012, 13, 50–60
Mi H., Haeberle H., Barres B.A., Induction of astrocyte differentiation by endothelial cells, J. Neurosci., 2001, 21, 1538–1547
Iadecola C., Nedergaard M., Glial regulation of the cerebral microvasculature, Nat. Neurosci., 2007, 10, 1369–1376
Koehler R.C., Roman R.J., Harder D.R., Astrocytes and the regulation of cerebral blood flow, Trends Neurosci., 2009, 32, 160–169
Schummers J., Yu H., Sur M., Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex, Science, 2008, 320, 1638–1643
Petzold G.C., Murthy V.N., Role of astrocytes in neurovascular coupling, Neuron, 2011, 71, 782–97
Carmignoto G., Gómez-Gonzalo M., The contribution of astrocyte signalling to neurovascular coupling, Brain Res. Rev., 2010, 63, 138–48
Yeager M., Harris A.L., Gap junction channel structure in the early 21st century: facts and fantasies, Curr. Opin. Cell. Biol., 2007, 19, 521–528
Theis M., Giaume C., Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res., 2012, 1487, 88–98
Dere E, Zlomuzica A., The role of gap junctions in the brain in health and disease, Neurosci. Biobehav. Rev., 2012, 36, 206–217
Volterra A., Meldolesi J., Astrocytes, from brain glue to communication elements: the revolution continues, Nat. Rev. Neurosci., 2005, 6, 626–640
Scemes E., Giaume C., Astrocyte calcium waves: what they are and what they do, Glia, 2006, 54, 716–725
Charles A., Teaching resources. Glial intercellular waves, Sci. STKE, 2005, 290, tr19
Bernardinelli Y., Magistretti P.J., Chatton J.Y., Astrocytes generate Na+-mediated metabolic waves, Proc. Natl. Acad. Sci. USA, 2004, 101, 14937–14942
Parpura V., Verkhratsky A., Homeostatic function of astrocytes: Ca(2+) and Na(+) signaling, Transl. Neurosci., 2012, 3, 334–344
Dreyfus C.F., Dai X., Lercher L.D., Racey B.R., Friedman W.J., Black I.B., Expression of neurotrophins in the adult spinal cord in vivo, J. Neurosci. Res., 1999, 56, 1–7
Schwartz J.P., Taniwaki T., Messing A., Brenner M., Somatostatin as a trophic factor. Analysis of transgenic mice overexpressing somatostatin in astrocytes, Ann. N.Y. Acad. Sci., 1996, 22, 29–35
Bögler O., Wren D., Barnett S.C., Land H., Noble M., Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells, Proc. Natl. Acad. Sci. USA, 1990, 87, 6368–63672
Noble M., Murray K., Stroobant P., Waterfield M.D., Riddle P., Plateletderived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell, Nature, 1988, 333, 560–562
Richardson W.D., Pringle N., Mosley M.J., Westermark B., Dubois-Dalcq M., A role for platelet-derived growth factor in normal gliogenesis in the central nervous system, Cell, 1988, 53, 309–319
Barres B.A., Schmid R., Sendnter M., Raff M.C., Multiple extracellular signals are required for long-term oligodendrocyte survival, Development, 1993, 118, 283–295
Sendtner M., Kreutzberg G.W., Thoenen H., Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy, Nature, 1990, 345, 440–441
Chernausek S.D., Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication, J. Neurosci. Res., 1993, 34, 189–197
Barnett S.C., Linington C., Myelination: Do Astrocytes Play a Role?, Neuroscientist, 2012, http://nro.sagepub.com/content/early/2012/11/05/1073858412465655
Blakemore W.F., Crang A.J., The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord, J. Neurocytol., 1989, 18, 519–528
Franklin R.J., Crang A.J., Blakemore W.F., Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord, J. Neurocytol., 1991, 20, 420–430
Sorensen A., Moffat K., Thomson C., Barnett S.C., Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axons in vitro, Glia, 2008, 56, 750–63
Nash B., Thomson C.E., Linington C., Arthur A.T., McClure J.D., McBride M.W., et al., Functional duality of astrocytes in myelination, J. Neurosci., 2011, 31, 13028–13038
Ishibashi T., Dakin K.A., Stevens B., Lee P.R., Kozlov S.V., Stewart C.L., et al., Astrocytes promote myelination in response to electrical impulses, Neuron, 2006, 49, 823–932
Kleopa K.A., Orthmann-Murphy J., Sargiannidou I., Gap junction disorders of myelinating cells, Rev. Neurosci., 2010, 21, 397–419
Tress O., Maglione M., Zlomuzica A., May D., Dicke N., Degen J., et al., Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacherlike disease in humans, PLoS Genet., 2011, 7, e1002146
Lutz S.E., Zhao Y., Gulinello M., Lee S.C., Raine C.S., Brosnan C.F., Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation, J. Neurosci., 2009, 29, 7743–7752
Verkhratsky A., Olabarria M., Noristani H.N., Yeh C.Y., Rodriguez J.J., Astrocytes in Alzheimer’s disease, Neurotherapeutics, 2010, 7, 399–412
Coulter D.A., Eid T., Astrocytic regulation of glutamate homeostasis in epilepsy, Glia, 2012, 60, 1215–1226
Rothstein J.D., Current hypotheses for the underlying biology of amyotrophic lateral sclerosis, Ann. Neurol., 2009, 65Suppl 1, S3–S9
Faideau M., Kim J., Cormier K., Gilmore R., Welch M., Auregan G., et al., In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington’s disease subjects, Hum. Mol. Genet., 2010, 19, 3053–3067
Simpson J.E., Ince P.G., Lace G., Forster G., Shaw P.J., Matthews F., et al., Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain, Neurobiol. Aging, 2010, 31, 578–590
Wang Y., Qin Z.H., Molecular and cellular mechanisms of excitotoxic neuronal death, Apoptosis, 2010, 15, 1382–1402
Carmignoto G., Haydon, P.G., Astrocyte calcium signaling and epilepsy, Glia, 2012, 60, 1227–1233
Schroder W., Seifert G., Huttmann K., Hinterkeuser S., Steinhauser C., AMPA receptor-mediated modulation of inward rectifier K+ channels in astrocytes of mouse hippocampus, Mol. Cell. Neurosci., 2002, 19, 447–458
D’Ambrosio R., Maris D.O., Grady M.S., Winn H.R., Janigro D., Impaired K(+) homeostasis and altered electrophysiological properties of post-traumatic hippocampal glia, Neurosci., 1999, 19, 8152–8162
Capendeguy O., Horisberger J.D., Functional effects of Na+,K+-ATPase gene mutations linked to familial hemiplegic migraine, Neuromolecular. Med., 2004, 6, 105–116
Sicca F., Imbrici P., D’Adamo M.C., Moro F., Bonatti F., Brovedani P., et al., Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1, Neurobiol. Dis., 2011, 43, 239–247
Nico B., Ribatti D., Role of aquaporins in cell migration and edema formation in human brain tumors, Exp. Cell. Res., 2011, 317, 2391–2396
Benga O., Huber V.J., Brain water channel proteins in health and disease. Mol. Aspects Med., 2012, 33, 562–578
Liu J.P., Tang Y., Zhou S., Toh B.H., McLean C., Li H., Cholesterol involvement in the pathogenesis of neurodegenerative diseases, Mol. Cell. Neurosci., 2010, 43, 33–42
Chen G., Li H.M., Chen Y.R., Gu X.S., Duan S., Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C, Glia, 2007, 55, 1509–1518
Kovács R., Heinemann U., Steinhäuser C., Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia, Epilepsia, 2012, 6, 53–59
Verkhratsky A., Parpura V., Recent advances in (patho)physiology of astroglia, Acta Pharmacol. Sin., 2010, 31, 1044–1054
Arundine M., Tymianski M., Molecular mechanisms of calciumdependent neurodegeneration in excitotoxicity, Cell Calcium, 2003, 34, 325–337
Mirza B., Hadberg H., Thomsen P., Moos T., The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson’s disease, Neuroscience, 2000, 95, 425–432
Zador Z., Stiver S., Wang V., Manley G.T., Role of aquaporin-4 in cerebral edema and stroke, Handb. Exp. Pharmacol., 2009, 190, 159–170
Sofroniew M.V., Molecular dissection of reactive astrogliosis and glial scar formation, Trends Neurosci., 2009, 32, 638–647
Eddleston M., Mucke L., Molecular profile of reactive astrocytesimplications for their role in neurological disease, Neuroscience, 1993, 54, 15–36
Argaw A.T., Asp L., Zhang J., Navrazhina K., Pham T., Mariani J.N., et al., Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease, J. Clin. Invest., 2012, 122, 2452–2468
Colombo E., Cordiglieri C., Melli G., Newcombe J., Krumbholz M., Parada L.F., et al., Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration, J. Exp. Med., 2012, 209, 521–535
Rossi D., Volterra A., Astrocytic dysfunction: insights on the role in neurodegeneration, Brain Res. Bull., 2009, 80, 224–232
Hinson S.R., McKeon A., Lennon V.A., Neurological autoimmunity targeting aquaporin-4, Neuroscience, 2010, 168, 1009–1018
Jarius S., Aboul-Enein F., Waters P., Kuenz B., Hauser A., Berger T., et al., Antibody to aquaporin-4 in the long-term course of neuromyelitis optica, Brain, 2008, 131, 3072–3080
Ratelade J., Verkman A.S., Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies, Int. J. Biochem. Cell. Biol., 2012, 44, 1519–1530
Haj-Yasein N.N., Vindedal G.F., Eilert-Olsen M., Gundersen G.A., Skare Ø., Laake P., et al., Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet, Proc. Natl. Acad. Sci. USA, 2011, 108, 17815–17820
Masaki K., Suzuki S.O., Matsushita T., Yonekawa T., Matsuoka T., Isobe N., et al., Extensive loss of connexins in Baló’s disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction, Acta Neuropathol., 2012, 123, 887–900
Matsuoka T., Suzuki S.O., Iwaki T., Tabira T., Ordinario A.T., Kira J., Aquaporin-4 astrocytopathy in Baló’s disease, Acta Neuropathol., 2010, 120, 651–660
Hazell A.S., Astrocytes are a major target in thiamine deficiency and Wernicke’s encephalopathy, Neurochem. Int., 2009, 55, 129–135
Hazell A.S., Rao K.V., Danbolt N.C., Pow D.V., Butterworth R.F., Selective down-regulation of the astrocyte glutamate transporters GLT-1 and GLAST within the medial thalamus in experimental Wernicke’s encephalopathy, J. Neurochem., 2001, 78, 560–568
Hazell A.S., Sheedy D., Oanea R., Aghourian M., Sun S., Jung J.Y., et al., Loss of astrocytic glutamate transporters in Wernicke encephalopathy, Glia, 2010, 58, 148–156
Hilgier W., Olson J.E., Brain ion and amino acid contents during edema development in hepatic encephalopathy, J. Neurochem., 1994, 62, 197–204
Schliess F., Görg B., Häussinger D., Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm, Biol. Chem., 2006, 387, 1363–1370
Butterworth R.F., Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy, Neurochem. Int., 2010, 57, 383–388
Brenner M., Johnson A.B., Boespflug-Tanguy O., Rodriguez D., Goldman J.E., Messing A., Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease, Nat. Genet., 2001, 27, 117–120
Li R., Messing A., Goldman J.E., Brenner M., GFAP mutations in Alexander disease, Int. J. Dev. Neurosci., 2002, 20, 259–268
Kohlschütter A., Eichler F., Childhood leukodystrophies: a clinical perspective, Expert Rev. Neurother., 2011, 11, 1485–1496
Kohlschütter A., Bley A., Brockmann K., Gärtner J., Krägeloh-Mann I., Rolfs A., et al., Leukodystrophies and other genetic metabolic leukoencephalopathies in children and adults, Brain Dev., 2010, 32, 82–89
Di Rocco M., Biancheri R., Rossi A., Filocamo M., Tortori-Donati P., Genetic disorders affecting white matter in the pediatric age, Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2004, 129B, 85–93
Boespflug-Tanguy O., Labauge P., Fogli A., Vaurs-Barriere C., Genes involved in leukodystrophies: a glance at glial functions, Curr. Neurol. Neurosci. Rep., 2008, 8, 217–229
Huyghe A., Horzinski L., Hénaut A., Gaillard M., Bertini E., Schiffmann R., et al., Developmental splicing deregulation in leukodystrophies related to EIF2B mutations, PLoS One, 2012, 7, e38264
Messing A., Brenner M., Feany M.B., Nedergaard M., Goldman J.E., Alexander disease, J. Neurosci., 2012, 32, 5017–5023
Bugiani M., Boor I., Powers J.M., Scheper G.C., van der Knaap M.S., Leukoencephalopathy with vanishing white matter: a review, J. Neuropathol. Exp. Neurol., 2010, 69, 987–996
van der Knaap M.S., Scheper G.C., Megalencephalic Leukoencephalopathy with Subcortical Cysts, In: Pagon R.A., Bird T.D., Dolan C.R., Stephens K., Adam M.P. (Eds.) GeneReviews? [Internet], Seattle (WA), University of Washington, Seattle; 1993–2003 Aug 11 [updated 2011 Nov 03]
Messing A., Goldman J.E., Alexander Disease, Elsevier, Amsterdam, 2004
Yoshida T., Nakagawa, M., Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation, Neuropathology, 2012, 32, 440–446
Salvi F., Aoki Y., Della Nave R., Vella A., Pastorelli F., Scaglione C., et al., Adult Alexander’s disease without leukoencephalopathy, Ann. Neurol., 2005, 58, 813–814
Barkovich A.J., Messing A., Alexander disease: not just a leukodystrophy anymore, Neurology, 2006, 66, 468–469
van der Knaap M.S., Ramesh V., Schiffmann R., Blaser S., Kyllerman M., Gholkar A., et al., Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord, Neurology, 2006, 66, 494–498
Tanaka K.F., Takebayashi H., Yamazaki Y., Ono K., Naruse M., Iwasato T., et al., The murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance, Glia, 2007, 55, 617–631
van der Voorn J.P., Pouwels P.J.W., Salomons G.S., Barkhof F., van der Knaap M., Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter, Neuroradiology, 2009, 51, 669–675
Iwaki T., Kume-Iwaki A., Liem R.K., Goldman J.E., Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander’s disease brain, Cell, 1989, 57, 71–78
Der Perng M., Su M., Wen S.F., Li R., Gibbon T., Prescott A.R., et al., The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27, Am J. Hum. Genet., 2006, 79, 197–213
Messing A., Head M.W., Galles K., Galbreath E.J., Goldman J.E., Brenner M., Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice, Am. J. Path., 1998, 152, 391–398
Hagemann T.L., Gaeta S.A., Smith M.A., Johnson D.A., Johnson J.A., Messing A., Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction, Hum. Mol. Genet., 2005, 14, 2443–2458
Tang G., Xu Z., Goldman J.E., Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease, J. Biol. Chem., 2006, 281, 38634–38643
Tang G., Perng M.D., Wilk S., Quinlan R., Goldman J.E., Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition, J. Biol. Chem., 2010, 285, 10527–10537
Mignot C., Boespflug-Tanguy O., Gelot A., Dautigny A., Pham-Dinh D., Rodriguez D., Alexander disease: putative mechanisms of an astrocytic encephalopathy, Cell. Mol. Life Sci., 2004, 61, 369–385
Hagemann T.L., Connor J.X., Messing A., Alexander diseaseassociated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response, J. Neurosci., 2006, 26, 11162–11173
Hagemann T.L., Boelens W.C., Wawrousek E.F., Messing A., Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease, Hum. Mol. Genet., 2009, 18, 1190–1199
Tian R., Wu X., Hagemann T.L., Sosunov A.A., Messing A., McKhann G.M., et al., Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes, J. Neuropathol. Exp. Neurol., 2010, 69, 335–345
Mignot C., Delarasse C., Escaich S., Della Gaspera B., Noé E., Colucci-Guyon E., et al., Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease, Exp. Cell. Res., 2007, 313, 2766–2779
Tang G., Yue Z., Talloczy Z., Goldman J.E., Adaptive autophagy in Alexander disease-affected astrocytes, Autophagy, 2008, 4, 701–713
Cho W., Messing A., Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice, Exp. Cell. Res., 2009, 315, 1260–1272
Chen B., Moreland J., Zhang J., Human brain functional MRI and DTI visualization with virtual reality, Quant. Imaging Med. Surg., 2011, 1, 11–16
van der Knaap M.S., Barth P.G., Stroink H., Van Nieuwenhuizen O., Arts W.F., Hoogenraad F., et al., Leukoncephalopathy with swelling and a discrepantly mild clinical course in eight children, Ann. Neurol., 1995, 7, 324–334
Singhal B.S., Gorospe J.R., Naidu S., Megalencephalic leukoencephalopathy with subcortical cysts, J. Child Neurol., 2003, 18, 646–652
Topku M., Saatci I., Topcuoglu M.A., Kose G., Kunak B., Megalencephaly and leukodystrophy with mild clinical course: a report on 12 new cases, Brain Dev., 1998, 20, 142–153
Goutières F., Boulloche J., Bourgeois M., Aicardi J., Leukoencephalopathy, megalencephaly, and mild clinical course. A recently individualized familial leukodystrophy. Report on five new cases, J. Child Neurol., 1996, 11, 439–444
Ben-Zeev B., Gross V., Kushnir T., Shalev R., Hoffman C., Shinar Y., et al., Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients, J. Child. Neurol., 2001, 16, 93–99
Riel-Romero R.M., Smith C.D., Pettigrew A.L., Megalencephalic leukoencephalopathy with subcortical cysts in two siblings owing to two novel mutations: case reports and review of the literature, J. Child. Neurol., 2005, 20, 230–234
Bugiani M., Moroni I., Bizzi A., Nardocci N., Bettecken T., Gärtner J., et al., Consciousness disturbances in megalencephalic leukoencephalopathy with subcortical cysts, Neuropediatrics, 2003, 34, 211–214
Leegwater P.A., Yuan B.Q., Van Der Steen J., Mulders J., Konst A.A., Boor P.K., et al., Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts, Am. J. Hum. Genet., 2001, 68, 831–838
Pascual-Castroviejo I., Viaño J., Pascual-Pascual S.I., Quiñones D., Congenital and evolving vascular disorders associated with cutaneous hemangiomas: case report, Neuropediatrics, 2009, 40, 148–151
Duarri A., de Heredia M.L., Capdevila-Nortes X., Ridder M.C., Montolio M., Lopez-Hernandez T., et al., Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model, Neurobiol. Dis., 2011, 43, 228–238
Leegwater P.A., Boor P.K., Yuan B.Q., van der Steen J., Visser A., Konst A.A., et al., Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts, Hum. Genet., 2002, 110, 279–283
Patrono C., Di Giacinto G., Eymard-Pierre E., Santorelli F.M., Rodriguez D., De Stefano N., et al., Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts, Neurology, 2003, 61, 534–537
Boor I.P.K., de Groot K., Mejaski-Bosnjak V., Brenner C., van der Knaap M.S., Scheper G.C., et al., Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1, Hum. Mutat., 2006, 27, 505–512
Teijido O., Casaroli-Marano R., Kharkovets T., Aguado F., Zorzano A., Palacín M., et al., Expression patterns of MLC1 protein in the central and peripheral nervous systems, Neurobiol. Dis., 2007, 26, 532–545
Boor P.K., de Groot K., Waisfisz Q., Kamphorst W., Oudejans C.B., Powers J.M., et al., MLC1 a novel protein in distal astroglial processes, J. Neuropathol. Exp. Neurol., 2005, 64, 412–419
Schmitt A., Gofferje V., Weber M., Meyer J., Mössner R., Lesch K.P., The brain-specific protein MLC1 implicated in megalencephalic leukoencephalopathy with subcortical cysts is expressed in glial cells in the murine brain, Glia, 2003, 44, 283–295
Ambrosini E., Serafini B., Lanciotti A., Tosini F., Scialpi F., Psaila R., et al., Biochemical characterization of MLC1 protein in astrocytes and its association with the dystrophin-glycoprotein complex, Mol. Cell. Neurosci., 2008, 37, 480–493
López-Hernández T., Ridder M.C., Montolio M., Capdevila-Nortes X., Polder E., Sirisi S., et al., Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism, Am. J. Hum. Genet., 2011, 88, 422–432
Jeworutzki E., López-Hernández T., Capdevila-Nortes X., Sirisi S., Bengtsson L., Montolio M., et al., GlialCAM, a protein defective in a leukodystrophy, serves as a CIC-2 Cl-channel auxiliary subunit, Neuron, 2012, 73, 951–961
Duarri A., Teijido O., López-Hernández T., Scheper G.C., Barriere H., Boor I., et al., Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects, Hum. Mol. Genet., 2008, 17, 3728–3739
Lanciotti A., Brignone M.S., Camerini S., Serafini B., Macchia G., Raggi C., et al., MLC1 trafficking and membrane expression in astrocytes: role of caveolin-1 and phosphorylation, Neurobiol. Dis., 2010, 37, 581–595
Brignone M.S., Lanciotti A., Macioce P., Macchia G., Gaetani M., Aloisi F., et al., The beta1 subunit of the Na, K-ATPase pump interacts with megalencephalic leucoencephalopathy with subcortical cysts protein 1 (MLC1) in brain astrocytes: new insights into MLC pathogenesis, Hum. Mol. Genet., 2011, 20, 90–103
Lanciotti A., Brignone M.S., Molinari P., Visentin S., De Nuccio C., Macchia G., et al., Megalencephalic leukoencephalopathy with subcortical cysts protein 1 functionally cooperates with the TRPV4 cation channel to activate the response of astrocytes to osmotic stress: dysregulation by pathological mutations, Hum. Mol. Genet., 2012, 21, 2166–2180
Benfenati V., Caprini M., Dovizio M., Mylonakou M.N., Ferroni S., Ottersen O.P., et al., An aquaporin-4/transient receptor potential vanilloid 4 (AQP4/TRPV4) complex is essential for cell-volume control in astrocytes, Proc. Natl. Acad. Sci. USA, 2011, 108, 2563–2568
Benfenati V., Amiry-Moghaddam M., Caprini M., Mylonakou M.N., Rapisarda C., Ottersen O.P., et al., Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes, Neuroscience, 2007, 148, 876–892
Bugiani M., Boor I., Powers J.M., Scheper G.C., van der Knaap M.S., Leukoencephalopathy with vanishing white matter: a review, J. Neuropathol. Exp. Neurol., 2010, 69, 987–996
van der Knaap M.S., Leegwater P.A., Könst A.A., Visser A., Naidu S., Oudejans C.B., et al., Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter, Ann. Neurol., 2002, 51, 264–270
Fogli A., Schiffmann R., Hugendubler L., Combes P., Bertini E., Rodriguez D., et al., Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients, Eur. J. Hum. Genet., 2004, 12, 561–566
van der Knaap M.S., Kamphorst W., Barth P.G., Kraaijeveld C.L., Gut E., Valk J., Phenotypic variation in leukoencephalopathy with vanishing white matter, Neurology, 1998, 51, 540–547
Dietrich J., Lacagnina M., Gass D., Richfield E., Mayer-Pröschel M., Noble M., et al., EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy, Nat. Med., 2005, 11, 277–283
Wong K., Armstrong R.C., Gyure K.A., Morrison A.L., Rodriguez D., Matalon R., et al., Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome, Acta Neuropathol., 2000, 100, 635–646
Rodriguez D., Gelot A., della Gaspera B., Robain O., Ponsot G., Sarlieve L.L., et al., Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases, Acta Neuropathol., 1999, 97, 469–480
Francalanci P., Eymard-Pierre E., Dionisi-Vici C., Boldrini R., Piemonte F., Virgili R., et al., Fatal infantile leukodystrophy: a severe variant of CACH/VWM syndrome, allelic to chromosome 3q27, Neurology, 2001,, 265–270
Bugiani M., Boor I., van Kollenburg B., Postma N., Polder E., van Berkel C., et al., Defective glial maturation in vanishing white matter disease, J. Neuropathol. Exp. Neurol., 2011, 70, 69–82
Geva M., Cabilly Y., Assaf Y., Mindroul N., Marom L., Raini G., et al., A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter, Brain, 2010, 133, 2448–2461
Kantor L., Pinchasi D., Mintz M., Hathout Y., Vanderver A., Elroy-Stein O., A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells, PLoS One, 2008, 3, e3783
van der Voorn J.P., van Kollenburg B., Bertrand G., Van Haren K., Scheper G.C., Powers J.M., et al., The unfolded protein response in vanishing white matter disease, J. Neuropathol. Exp. Neurol., 2005, 64, 770–775
Huyghe A., Horzinski L., Hénaut A., Gaillard M., Bertini E., Schiffmann R., et al., Developmental splicing deregulation in leukodystrophies related to EIF2B mutations, PLoS One, 2012, 7, e38264
Bugiani M., Postma N., Polder E., Dieleman N., Scheffer P.G., Sim F.J., et al., Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease, Brain, 2013, 136, 209–222
Sloane J.A., Batt C., Ma Y., Harris Z.M., Trapp B., Vartanian T., Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2, Proc. Natl. Acad. Sci. USA, 2010, 107, 11555–11560
McAllister T.W., Neurobiological consequences of traumatic brain injury, Dialogues Clin. Neurosci., 2011, 13, 287–300
Biddle C., The neurobiology of the human febrile response, AANA J., 2006, 74, 145–50
Combes V., Guillemin G.J., Chan-Ling T., Hunt N.H., Grau G.E., The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes, Trends Parasitol., 2012, 28, 311–319
Molofsky A.V., Krencik R., Ullian E.M., Tsai H.H., Deneen B., Richardson W.D., et al., Astrocytes and disease: a neurodevelopmental perspective, Genes Dev., 2012, 26, 891–907
Gibbs M.E., Bowser D.N., Hutchinson D.S., Loiacono R.E., Summers R.J., Memory processing in the avian hippocampus involves interactions between beta-adrenoceptors, glutamate receptors, and metabolism, Neuropsychopharmacology, 2008, 33, 2831–2846
Halassa M.M., Florian C., Fellin T., Munoz J.R., Lee S.Y., Abel T., et al., Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss, Neuron, 2009, 61, 213–219
Gourine A.V., Kasymov V., Marina N., Tang F., Figueiredo M.F., Lane S., et al., Astrocytes control breathing through pH-dependent release of ATP, Science, 2010, 329, 571–575
Christensen R.K., Petersen A.V., Perrier J.F., How do glial cells contribute to motor control, Curr. Pharm. Des., 2013, [Epub ahead of print]_doi: CPD-EPUB-20130121-5
Verkhratsky A., Sofroniew M.V., Messing A., de Lanerolle N.C., Rempe D., Rodríguez J.J., et al., Neurological diseases as primary gliopathies: a reassessment of neurocentrism, ASN Neuro., 2012, 4, e00082
Oberheim N.A., Goldman S.A., Nedergaard M., Heterogeneity of astrocytic form and function, Methods Mol. Biol., 2012, 814, 23–45
Kimelberg H.K., Nedergaard M., Functions of astrocytes and their potential as therapeutic targets, Neurotherapeutics, 2010, 7, 338–353
Jeong S.R., Kwon M.J., Lee H.G., Joe E.H., Lee J.H., Kim S.S., et al., Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury, Exp. Neurol., 2012, 233, 312–222
Fontana A.C., de Oliveira Beleboni R., Wojewodzic M.W., Ferreira Dos Santos W., Coutinho-Netto J., Grutle N.J., et al., Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom, Mol. Pharmacol., 2007, 72, 1228–1237
Escartin C., Bonvento G., Targeted activation of astrocytes: a potential neuroprotective strategy, Mol. Neurobiol., 2008, 38, 231–241
Gupta K., Patani R., Baxter P., Serio A., Story D., Tsujita T., et al., Human embryonic stem cell derived astrocytes mediate non-cellautonomous neuroprotection through endogenous and druginduced mechanisms, Cell Death Differ., 2012, 19, 779–787
Krencik R., Zhang S.C., Directed differentiation of functional astroglial subtypes from human pluripotent stem cells, Nat. Protoc., 2011, 6, 1710–1717
Goldman S.A., Nedergaard M., Windrem M.S., Glial progenitor cellbased treatment and modeling of neurological disease, Science, 2012, 338, 491–495
Juopperi T.A., Kim W.R., Chiang C.H., Yu H., Margolis R.L., Ross C.A., et al., Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells, Mol. Brain, 2012, 5, 17
Noble M., Davies J.E., Mayer-Pröschel M., Pröschel C., Davies S.J., Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury, Neurotherapeutics, 2011, 8, 677–693
Davies S.J., Shih C.H., Noble M., Mayer-Proschel M., Davies J.E., Proschel C., Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury, PLoS One, 2011, 6, e17328
Lee H.J., Lim I.J., Park S.W., Ko Y.B., Kim S.U., Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in mouse with ibotenic acid-induced cognitive dysfunction, Cell Transplant., 2012, 21, 2487–2496
Jin Y., Neuhuber B., Singh A., Bouyer J., Lepore A., Bonner J., et al., Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury, J. Neurotrauma, 2011, 28, 579–594
Van Dycke A., Raedt R., Verstraete A., Theofilas P., Wadman W., Vonck K., et al., Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery, Seizure, 2010, 19, 390–396
Hayashi K., Hashimoto M., Koda M., Naito A.T., Murata A., Okawa A., et al., Increase of sensitivity to mechanical stimulus after transplantation of murine induced pluripotent stem cell-derived astrocytes in a rat spinal cord injury model, J. Neurosurg. Spine, 2011, 15, 582–593
Lepore A.C., O’Donnell J., Kim A.S., Williams T., Tuteja A., Rao M.S., et al., Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS, PLoS One, 2011, 6, e25968
Corti S., Nizzardo M., Simone C., Falcone M., Donadoni C., Salani S., et al., Direct reprogramming of human astrocytes into neural stem cells and neurons, Exp. Cell. Res., 2012, 318, 1528–1541
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Lanciotti, A., Brignone, M.S., Bertini, E. et al. Astrocytes: Emerging stars in leukodystrophy pathogenesis. Translat.Neurosci. 4, 144–164 (2013). https://doi.org/10.2478/s13380-013-0118-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s13380-013-0118-1